Clinical trial
Observational, Prospective, Parallel Cohort Study to Evaluate Tolerability of Canagliflozin and Sulphonylurea on a Background Therapy of Metformin With or Without a DPP-4 Inhibitor During Ramadan Fasting in Patients With Type 2 Diabetes
NCT02737657 is registered in ClinicalTrials.gov with Janssen-Cilag International NV as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational, Prospective, Parallel Cohort Study to Evaluate Tolerability of Canagliflozin and Sulphonylurea on a Background Therapy of Metformin With or Without a DPP-4 Inhibitor During Ramadan Fasting in Patients With Type 2 Diabetes
- Lead sponsor
- Janssen-Cilag International NV
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2016
- Completion date
- September 30, 2016
- Enrollment
- 379 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.